Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women.
Papapoulos
Socrates E
SE
Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. m.v.iken@lumc.nl
Quandt
Sara A
SA
Liberman
Uri A
UA
Hochberg
Marc C
MC
Thompson
Desmond E
DE
D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D019386:Alendronate / Q000627:therapeutic use*; D015519:Bone Density / Q000187:drug effects; D005260:Female; D006620:Hip Fractures / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000150:complications* / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D019386:Alendronate